FDA.reportPublic FDA data

PALIPERIDONE

Substance profile for UNII 838F01T721, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for PALIPERIDONE
Structure render from PubChem CID 115237

Substance Identity#

UNII
838F01T721
Preferred term
PALIPERIDONE
Registry number
144598-75-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C23H27FN4O3
Chemical structure for PALIPERIDONE
Structure render from PubChem CID 115237

Chemical And Database Identifiers#

SMILES
CC1=C(CCN2CCC(CC2)C3=NOC4=C3C=CC(F)=C4)C(=O)N5CCCC(O)C5=N1
RxCUI
679314
PubChem
115237
NCIt
C66293
INN ID
7977

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound115237https://pubchem.ncbi.nlm.nih.gov/compound/115237
RxNorm679314https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=679314
NCI ThesaurusC66293https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C66293
FDA Substance Registration System838F01T721https://precision.fda.gov/uniisearch/srs/unii/838F01T721

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
paliperidoneACTIVE MOIETY838F01T721These highlights do not include all the information needed to use INVEGA safely and effectively. See full prescribing information for INVEGA . INVEGA (paliperidone) Extended-Release Tablets Initial U.S. Approval: 2006 ® ® ®2
paliperidoneACTIVE INGREDIENT838F01T721These highlights do not include all the information needed to use INVEGA safely and effectively. See full prescribing information for INVEGA . INVEGA (paliperidone) Extended-Release Tablets Initial U.S. Approval: 2006 ® ® ®2
paliperidoneACTIVE INGREDIENT838F01T721These highlights do not include all the information needed to use INVEGA ® safely and effectively. See full prescribing information for INVEGA ® . INVEGA ® (paliperidone) Extended-Release Tablets Initial U.S. Approval: 20061
paliperidoneACTIVE MOIETY838F01T721These highlights do not include all the information needed to use INVEGA ® safely and effectively. See full prescribing information for INVEGA ® . INVEGA ® (paliperidone) Extended-Release Tablets Initial U.S. Approval: 20061
paliperidoneACTIVE MOIETY838F01T721INVEGA SUSTENNA (PALIPERIDONE PALMITATE) INJECTION [JANSSEN PHARMACEUTICALS, INC.]19
PALIPERIDONEACTIVE MOIETY838F01T721PALIPERIDONE TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]18
PALIPERIDONEACTIVE INGREDIENT838F01T721PALIPERIDONE TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]18
paliperidoneACTIVE INGREDIENT838F01T721INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [JANSSEN PHARMACEUTICALS, INC.]17
paliperidoneACTIVE MOIETY838F01T721INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [JANSSEN PHARMACEUTICALS, INC.]17
PALIPERIDONEACTIVE INGREDIENT838F01T721PALIPERIDONE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]2
PALIPERIDONEACTIVE MOIETY838F01T721PALIPERIDONE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]2
PALIPERIDONEACTIVE INGREDIENT838F01T721INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ]1
PALIPERIDONEACTIVE MOIETY838F01T721INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ]1
paliperidoneACTIVE MOIETY838F01T721INVEGA TRINZA (PALIPERIDONE PALMITATE) INJECTION, SUSPENSION, EXTENDED RELEASE [JANSSEN PHARMACEUTICALS, INC]1
paliperidoneACTIVE INGREDIENT838F01T721PALIPERIDONE TABLET, EXTENDED RELEASE [AVERA MCKENNAN HOSPITAL]1
paliperidoneACTIVE MOIETY838F01T721PALIPERIDONE TABLET, EXTENDED RELEASE [AVERA MCKENNAN HOSPITAL]1
paliperidoneACTIVE MOIETY838F01T721PALIPERIDONE TABLET, EXTENDED RELEASE [AVERA MCKENNAN HOSPITAL]1
paliperidoneACTIVE INGREDIENT838F01T721PALIPERIDONE TABLET, EXTENDED RELEASE [AVERA MCKENNAN HOSPITAL]1
paliperidoneACTIVE MOIETY838F01T721PALIPERIDONE TABLET, EXTENDED RELEASE [PATRIOT PHARMACEUTICALS, LLC]1
paliperidoneACTIVE INGREDIENT838F01T721PALIPERIDONE TABLET, EXTENDED RELEASE [PATRIOT PHARMACEUTICALS, LLC]1